Frost edit · Free shipping over $70 · Cool essentials
hengrui glp 1

hengrui glp 1 Pharma's GLP-1R Agonist Patent Disclosure Hengrui Pharma and Kailera Therapeutics

SKU: 66494033485
4.8
USD26.44 USD54.44

Pay in 4 interest-free payments of $6.61 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Oct 12 - Oct 17

Description

Yang, K., Doan, M

hengrui glp 1 Pharma's GLP-1R Agonist Patent Disclosure Hengrui Pharma and Kailera Therapeutics

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

hengrui glp 1 Pharma's GLP-1R Agonist Patent Disclosure Hengrui Pharma and Kailera Therapeutics

10.21873/invivo.12309 In Vivo

hengrui glp 1 Pharma's GLP-1R Agonist Patent Disclosure Hengrui Pharma and Kailera Therapeutics

Key Product Features High purity strictly validated by RP-HPLC and mass spectrometry testing Triple GLP-1/GIP/GCGR activation with ultimate synergistic biological activity Optimized peptide structure with strong hydrolysis resistance and experimental stability Ultra-low endotoxin level, suitable for cell experiments and in vivo animal research Factory direct sales with full quality traceability and complete inspection reports Customizable specifications and packaging for academic and industrial research scenarios Technical Specifications Product Name : Retatrutide (GLP-3 R) Appearance : White lyophilized powder Purity : 99% (research grade optional) Molecular Weight : 4997.5 Da Endotoxin : 0.1 EU/g Quality Control : HPLC, MS, moisture analysis, endotoxin test Storage : Sealed at room temperature, avoid direct sunlight and humid environment Research Applications Type 2 diabetes and severe insulin resistance mechanism research Severe obesity intervention and whole-body energy metabolism studies Fatty liver lesions and systemic lipid metabolism regulation exploration Endocrine regulation and triple-receptor pharmacological mechanism research Metabolic inflammation and pathological correlation experimental research Preclinical high-standard metabolic model construction and efficacy testing Important Statement For Research Use Only (RUO) This product is exclusively for scientific laboratory research use only

hengrui glp 1 Pharma's GLP-1R Agonist Patent Disclosure Hengrui Pharma and Kailera Therapeutics

ordre: 2 pices Livraison avant le 09 mars 5 Vendu Guangzhou City Panyu District Mengman Cosmetics Firm (individual Business) 2 AnsCN4.5/5.0 12% Taux de rachat 307 clients intresss 1/1 Correspond tous les Gluta & Collagne Pilules Mcher L-Gluta 13 en 1 Formule Gummy Vitamins Supplments pour les Rides et l'claircissement de la Peau 2,65-3,35 $ Min

hengrui glp 1 Pharma's GLP-1R Agonist Patent Disclosure Hengrui Pharma and Kailera Therapeutics

Buay, J., Larriba, E., Moreno, R

hengrui glp 1 Pharma's GLP-1R Agonist Patent Disclosure Hengrui Pharma and Kailera Therapeutics
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products